Professor, Psychiatry, Drexel College of Medicine/Hahnemann School of Medicine
Psychiatry
Dr. Paul J. Ambrosini, MD
|
|
Give Review
Paul Ambrosini is an expert in the field of Psychiatry. He went to medical school at Wake Forest School of Medicine. Paul Ambrosini is also a published MD. He has 53 paper published. The most recent paper is: Increased plasma valproate concentrations when coadministered with guanfacine.
Publications
- Tourette syndrome associated with attention deficit hyperactivity disorder: The impact of tics and psychopharmacological treatment options.
- Attention deficit hyperactivity disorder characteristics: II. Clinical correlates of irritable mood.
- Taxonicity of adolescent melancholia: a categorical or dimensional construct?
- Psychotropic prescription practices in child psychiatric inpatients 9 years old and younger.
- Gender differences in adolescent depression: do symptoms differ for boys and girls?
- A community assessment, open-label study of the safety, tolerability, and effectiveness of mixed amphetamine salts extended release in school-age children with ADHD.
- Cardiovascular effects of mixed amphetamine salts extended release in the treatment of school-aged children with attention-deficit/hyperactivity disorder.
- Nocturnal enuresis: a suggestive endophenotype marker for a subgroup of inattentive attention-deficit/hyperactivity disorder.
- ADHD latent class clusters: DSM-IV subtypes and comorbidity.
- Parental ADHD status and its association with proband ADHD subtype and severity.
- What can ADHD without comorbidity teach us about comorbidity?
- Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials.
- Sertraline in children and adolescents with major depressive disorder.
- ADHD characteristics: I. Concurrent co-morbidity patterns in children & adolescents.
- Candidate gene analysis in an on-going genome-wide association study of attention-deficit hyperactivity disorder: suggestive association signals in ADRA1A.
- Long-term sertraline treatment of children and adolescents with major depressive disorder.
- Antidepressant treatments in children and adolescents. I. Affective disorders.
- Multicenter open-label sertraline study in adolescent outpatients with major depression.
- Antidepressant treatments in children and adolescents: II. Anxiety, physical, and behavioral disorders.
- Concurrent validity and psychometric properties of the Beck Depression Inventory in outpatient adolescents.
- Prolactin secretion in depressed children.
- Relative safety of single versus divided dose imipramine in adolescent major depression.
- The dexamethasone suppression test in adolescent outpatients with major depressive disorder.
- Regulation of sleep and growth hormone in adolescent depression.
- Dexamethasone suppression test in children with major depressive disorder.
- Relationship of Beck Depression Inventory factors to depression among adolescents.
- Platelet imipramine binding in depressed children and adolescents.
- The 24-hour pattern of prolactin secretion in depressed and normal adolescents.
- Videotape reliability of the third revised edition of the K-SADS.
- Treatment of attention-deficit-hyperactivity disorder.
- The clinical picture of major depression in children and adolescents.
- Hormonal responses to dextroamphetamine in depressed and normal adolescents.
- MAOIs in adolescent major depression unresponsive to tricyclic antidepressants.
- Imipramine in adolescent major depression: plasma level and clinical response.
- Increased plasma valproate concentrations when coadministered with guanfacine.
- 49th Annual Meeting of the American Academy of Child & Adolescent Psychiatry. 22-27 October 2002, San Francisco, CA, USA.
- Historical development and present status of the schedule for affective disorders and Schizophrenia for school-age children (K-SADS).
- A review of pharmacotherapy of major depression in children and adolescents.
- The psychosocial functioning and family environment of depressed adolescents.
- Growth hormone response to desmethylimipramine in depressed and suicidal adolescents.
- Electroencephalographic sleep of adolescents with major depression and normal controls.
- Pancreatitis associated with serotonin-dopamine antagonists.
- The assessment of affective disorders in children and adolescents by semistructured interview. Test-retest reliability of the schedule for affective disorders and schi...
- Childhood depression: pharmacological therapy/treatment (pharmacotherapy of childhood depression).
- Thyroid stimulating hormone response to thyrotropin in prepubertal depression.
- Molindone hydrochloride treatment of hospitalized children with conduct disorder.
- Does guanfacine cause hallucinations in children?
- Cortisol secretion in adolescents with major depressive disorder.
- Imipramine binding in agoraphobia.
- A children's global assessment scale (CGAS).
- Growth hormone secretion in prepubertal children with major depression. III. Response to insulin-induced hypoglycemia after recovery from a depressive episode and in a...
- Growth hormone secretion in prepubertal children with major depression. I. Final report on response to insulin-induced hypoglycemia during a depressive episode.
Schools
Wake Forest University
Ny Hospital
Psychology Institute
Conditions Treated
- Schizophrenia
Doctors Specialties
- Pediatric Psychiatry
- Psychiatry
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Community Blue PPO
- Choice Care PPO
- Medicare MCR
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Education
-
New York Presbyterian Hospital - Columbia Campus -
Wake Forest School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Eliza N. Wilfred, MD |
|
|
Dr. Susan V. McLeer, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard W. Cohen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Harris M. Rabinovich, MD
This Doctor is OpenDoctor Recommended.
|